TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Salipro Biotech AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,268
|
4,009
|
4,990 |
| Financial expenses |
1
|
1
|
0 |
| Earnings before taxes |
-2,956
|
-2,864
|
-1,608 |
| EBITDA |
-2,486
|
-2,491
|
-1,234 |
| Total assets |
7,012
|
10,492
|
13,114 |
| Current assets |
2,955
|
6,411
|
9,536 |
| Current liabilities |
949
|
1,164
|
985 |
| Equity capital |
6,063
|
9,328
|
12,129 |
| - share capital |
45
|
46
|
46 |
| Employees (average) |
8
|
9
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
86.5%
|
88.9%
|
92.5% |
| Turnover per employee |
534
|
445
|
713 |
| Profit as a percentage of turnover |
-69.3%
|
-71.4%
|
-32.2% |
| Return on assets (ROA) |
-42.1%
|
-27.3%
|
-12.3% |
| Current ratio |
311.4%
|
550.8%
|
968.1% |
| Return on equity (ROE) |
-48.8%
|
-30.7%
|
-13.3% |
| Change turnover |
392
|
-1,008
|
1,977 |
| Change turnover % |
10%
|
-20%
|
66% |
| Chg. No. of employees |
-1
|
2
|
1 |
| Chg. No. of employees % |
-11%
|
29%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.